Fresenius SE Gross Margin 2016-2023 | FSNUY

Current and historical gross margin for Fresenius SE (FSNUY) over the last 10 years. The current gross profit margin for Fresenius SE as of September 30, 2023 is %.
Fresenius SE Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2023-09-30 $39.20B $9.48B 24.18%
2023-06-30 $43.73B $10.82B 24.74%
2023-03-31 $43.10B $11.12B 25.81%
2022-12-31 $43.03B $11.30B 26.26%
2022-09-30 $43.53B $11.55B 26.54%
2022-06-30 $43.99B $11.80B 26.83%
2022-03-31 $44.47B $12.11B 27.22%
2021-12-31 $44.39B $12.20B 27.48%
2021-09-30 $44.08B $12.18B 27.63%
2021-06-30 $43.51B $12.13B 27.88%
2021-03-31 $42.19B $11.79B 27.94%
2020-12-31 $41.44B $11.78B 28.44%
2020-09-30 $40.66B $11.71B 28.81%
2020-06-30 $40.06B $11.64B 29.05%
2020-03-31 $40.09B $11.71B 29.20%
2019-12-31 $39.66B $11.59B 29.22%
2019-09-30 $39.42B $11.57B 29.35%
2019-06-30 $39.12B $11.50B 29.40%
2019-03-31 $39.27B $11.59B 29.50%
2018-12-31 $39.60B $11.62B 29.33%
2018-09-30 $39.76B $11.76B 29.57%
2018-06-30 $39.98B $11.90B 29.77%
2018-03-31 $39.37B $11.85B 30.09%
2017-12-31 $38.30B $11.84B 30.92%
2017-09-30 $36.47B $11.40B 31.26%
2017-06-30 $34.84B $11.03B 31.65%
2017-03-31 $33.47B $10.61B 31.70%
2016-12-31 $32.18B $10.10B 31.39%
2016-09-30 $31.71B $15.35B 48.42%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $18.408B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00